...
首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention
【24h】

Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention

机译:初步经皮冠状动脉介入后测定微循环抗性指数的预测值

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Most methods for assessing microvascular function are not readily available in the cardiac catheterization laboratory. The aim of this study is to determine whether the Index of Microcirculatory Resistance (IMR), measured at the time of primary percutaneous coronary intervention, is predictive of death and rehospitalization for heart failure. Methods and Results: IMR was measured immediately after primary percutaneous coronary intervention in 253 patients from 3 institutions with the use of a pressure-temperature sensor wire. The primary end point was the rate of death or rehospitalization for heart failure. The prognostic value of IMR was compared with coronary flow reserve, TIMI myocardial perfusion grade, and clinical variables. The mean IMR was 40.3±32.5. Patients with an IMR >40 had a higher rate of the primary end point at 1 year than patients with an IMR ≥40 (17.1% versus 6.6%; P=0.027). During a median follow-up period of 2.8 years, 13.8% experienced the primary end point and 4.3% died. An IMR >40 was associated with an increased risk of death or rehospitalization for heart failure (hazard ratio [HR], 2.1; P=0.034) and of death alone (HR, 3.95; P=0.028). On multivariable analysis, independent predictors of death or rehospitalization for heart failure included IMR >40 (HR, 2.2; P=0.026), fractional flow reserve ≤0.8 (HR, 3.24; P=0.008), and diabetes mellitus (HR, 4.4; P<0.001). An IMR >40 was the only independent predictor of death alone (HR, 4.3; P=0.02). Conclusions: An elevated IMR at the time of primary percutaneous coronary intervention predicts poor long-term outcomes.
机译:背景:在心脏导管插入实验室中,大多数评估微血管功能的方法都不容易获得。本研究的目的是确定在初生经皮冠状动脉干预时测量的微循环性耐药性(IMR)的指数是否可预测心力衰竭的死亡和再生。方法和结果:IMR在253名机构的主要经皮冠状动脉干预后立即测量,使用压力温度传感器线。主要终点是心力衰竭的死亡率或再生。将IMR的预后值与冠状动脉储备,TIMI心肌灌注等级和临床变量进行比较。平均IMR为40.3±32.5。患有IMR> 40的患者比IMR≥40的患者在1年的初级终点率较高(17.1%对6.6%; P = 0.027)。在2.8岁的中位随访期间,13.8%经历了主要终点,4.3%死亡。 IMR> 40与心力衰竭(危害比[HR],2.1; P = 0.034)和单独死亡(HR,3.95; P = 0.028)的死亡或死亡风险增加有关。对多变量分析,心力衰竭死亡或再生的独立预测因子包括IMR> 40(HR,2.2; P = 0.026),分数流量储备≤0.8(HR,3.24; P = 0.008),糖尿病(HR,4.4; P <0.001)。 IMR> 40是单独死亡的唯一独立预测因子(HR,4.3; P = 0.02)。结论:原发性经皮冠状动脉干预时的IMR升高预测了差的长期结果。

著录项

  • 来源
  • 作者单位

    Division of Cardiovascular Medicine Stanford University Medical Center 300 Pasteur Dr H2103;

    National University Heart Centre Singapore Singapore;

    Division of Cardiovascular Medicine Stanford University Medical Center 300 Pasteur Dr H2103;

    Department of Cardiology Golden Jubilee National Hospital Glasgow United Kingdom;

    Department of Cardiology Golden Jubilee National Hospital Glasgow United Kingdom;

    Division of Cardiovascular Medicine Stanford University Medical Center 300 Pasteur Dr H2103;

    Division of Cardiovascular Medicine Stanford University Medical Center 300 Pasteur Dr H2103;

    Division of Cardiovascular Medicine Stanford University Medical Center 300 Pasteur Dr H2103;

    National University Heart Centre Singapore Singapore;

    Department of Cardiology Golden Jubilee National Hospital Glasgow United Kingdom;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏、血管(循环系)疾病;
  • 关键词

    Microcirculation; Myocardial infarction; Physiology;

    机译:微循环;心肌梗死;生理学;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号